Background: Poor access to contraception contributes to persistently high maternal mortality rates in Papua New Guinea (PNG). Since 2012 contraceptive implants have been provided to women in rural areas of PNG through outreach services but follow-up data in these communities on continuation and acceptability is lacking.
INTRODUCTION
Papua New Guinea (PNG) is a developing country that continues to face significant geographical, cultural, health service and economic barriers to the provision of maternal and reproductive health care. 1 Consequently modern contraceptive prevalence remains low at 15% for all women and the total unmet need for contraception persists at 25 percent. 2, 3 This contributes to a high maternal mortality ratio (MMR), estimated to be 500-700/100 000 live births.
2
Leading international organisations have established that the use of reliable contraception, including long-acting reversible contraceptives (LARC), is one of the most effective methods for lowering maternal mortality. [4] [5] [6] [7] [8] LARC methods, including intrauterine devices and subdermal implants, confer rapidly reversible effective contraception for extended periods of time. 7 It is estimated that over the next decade unintended pregnancies in PNG could be reduced by 50% and maternal deaths from unsafe abortion by 90% through improved access to effective contraception.
7,8
Further, cost-effectiveness analyses predict that for every US dollar spent on effective contraception, a four-fold reduction in health costs associated with intrapartum morbidity could be achieved.
8,9
Since 2012, implants in PNG have been primarily distrib- Most outreach projects utilise the Jadelle or Sino 2 implant: a subcutaneous two rod contraceptive implant containing a total of 150 mg levonorgestrel which provides reliable and effective contraception for up to five years. 10 Twelve month follow-up data for the Sino 2 Implant in similar low-resource settings in Kenya, Pakistan and Madagascar demonstrated low pregnancy probabilities (0-0.1%), low discontinuation rates (< 10%) and high user satisfaction (> 80%) scores.
10-12
Despite widespread uptake of implants in PNG no follow-up data evaluating women's experiences with this contraceptive method currently exist. In this study, we aimed to assess the acceptability, satisfaction, continuation rates and efficacy of contraceptive implants among women in rural PNG who had an implant inserted at least 12 months prior to the survey. 
MATERIALS AND METHODS

Between
Statistical analysis
The data were analysed using SPSS Version 21.0 (SPSS Inc., Chicago, IL, USA). All questionnaires included for analyses were completed in full and descriptive statistics were performed.
Degree of association between socio-demographic factors, side effects and satisfaction scores were assessed using chi-square tests. Women were grouped according to age (< 25 years, > 25 years), level of education (primary < year 9, secondary or higher > year 9) and place of residence. P-values <0.05 were considered statistically significant.
RESULTS
Seven thousand and thirty-eight women were identified by health records as having had an implant inserted prior to October 2013.
In the eight-week study period researchers approached 911 women, of whom six did not provide consent and 45 did not complete the questionnaires. The following results are based on a cohort of 860 women. Table 1 summarises the demographic profile of the participants. The mean number of children per woman was two (range 0-9) and almost two-thirds (n = 530, 62%) did not want any more children. Fifty-two percent of women had previously used family planning methods. Depot medroxyprogesterone acetate and/ or the oral contraceptive pill were the most commonly employed methods (n = 304, 69%). Table 2 summarises the 12 month continuation rates, side effect profile and overall satisfaction scores for contraceptive implants among all women in the study. Seven women gave birth to an infant after insertion of the implant, corresponding with a failure rate of 0.8%. Five of these women gave birth between six and eight months after insertion of the implant. One woman birthed an infant 11 months and another 18 months after insertion of the implant. Appropriate placement of the device had been confirmed and checked by researchers in all of these cases.
The majority of women (n = 654, 76%) did not report any side effects from using the contraceptive implant. Of those who reported at least one side effect, irregular bleeding was the most frequently reported problem (n = 178/205, 87%). Seven percent (n = 13/178) of these women reported the bleeding to be bothersome (ie unpleasant enough to report to friends and health workers) but only three women had the implant removed for this reason.
Almost all women (n = 822/860, 95%) were 'very happy' with the implant. Ninety-seven percent of women still had the implant in situ at 12 months (n = 836/860) with desire for more children being the most common reason for removal (n = 9/18, 50%). Only three women had the device removed due to bothersome bleeding (n = 3/18, 17%). Over 90% of women (n = 793/860, 92%) indicated they would use the implant again in the future. Half of the women (n = 437/860) acknowledged they had been discouraged from using the device by church members and/or fellow villagers but this was not a reported reason for removal. Twelve month continuation rates, overall satisfaction and side effect incidence were not significantly associated with age (< 25 years vs ≥ 25 years), completed level of education (none, secondary, tertiary) or place of residence (P = 0.475, P = 0.324, P = 2.87, respectively).
DISCUSSION
This study demonstrates that women provided with the contraceptive implant in rural PNG have very high 12 month continuation rates, high satisfaction scores and low failure rates and these results do not significantly differ with respect to user age, level of education or place of residence. In contrast to high resource settings where despite pre-insertion counselling, up to 50% of implant use is discontinued because of dissatisfaction with bleeding patterns, 13 in our cohort implant removal was mostly motivated by desire to continue childbearing. It is evident that outreach services have been successful in familiarising women with the contraceptive implant and expanding access to those with an unmet need for contraception as less than one-quarter knew about the implant prior to adopting it and at the time of implant insertion half of the cohort were not using any contraceptive method.
High continuation rates in this cohort may have been influenced by limited access to removal services and equipment (eg local anaesthetic and artery forceps) which is a particular issue in rural communities. 9 However, we can be reasonably confident that this was not a significant contributing factor because the majority of women were very happy with the device and indicated that they would use it again. Irregular bleeding was the most commonly reported side effect among our participants, which is consistent with self-reporting in other countries, 10,14 but this alone was not a major motivator for device removal. Irregular bleeding appears to be a larger contributor to implant removal in other low resource settings, resulting in up to 35% of removals within 12 months in Kenyan and Pakistani cohorts.
10
Failure rates in our cohort could not be accurately calculated and were considerably higher than other cohorts in low resource settings. 10, 11 Access to reliable early pregnancy testing in rural PNG is virtually non-existent and in the current outreach service model pregnancy testing could not practicably be offered to women prior to implant insertion. Instead, programs used the last menstrual period to qualify women for the device. Five of the seven women included in the failure rate who completed pregnancies 6-8 months after insertion of the implant could have had the implant inserted in the early stages of an unknown pregnancy, thus over-estimating the true failure rate. Conversely, inability to record instances of all pregnancies as well as miscarriages occurring after device insertion has the potential to underestimate failure rates in this setting. Failure rates in our cohort therefore likely reflect a combination of product and process failure and may be lower if pregnancy testing had been available prior to implant insertion. Accounting for this however, the total percentage of pregnancies occurring with the device in situ (n = 7, 0.8%) still fell below manufacturer-quoted failure rates of 1%. 15 In settings such as PNG where implants have the potential to significantly lower maternal mortality and morbidity, device insertion without prior exclusion of pregnancy may be appropriate if pre-testing remains challenging. Exogenous progestin in pregnancy does not appear to be associated with adverse maternal, fetal or neonatal outcomes, 16, 19 so this approach is safe as well as pragmatic.
Theoretically, these women will also continue to receive effective and immediate contraception post-natally that does not impact on their ability to breastfeed and is in accordance with the latest 2016 WHO Medical Eligibility Criteria recommendations. [16] [17] [18] [19] This approach however is novel and is unsupported by current practice guidelines and requires validation by further research.
Outreach programs have the potential to overcome many of the complex supply chain dynamics that impair the delivery of other methods, including pills and injectables. Implants last for up to five years which protects against resource depletion and improves cost effectiveness. Support to expand access to outreach implant services also comes from the extensive health and socioeconomic benefits of access to reliable contraception: reduced risk of post-partum haemorrhage, reduced risk of complications associated with unsafe abortion, control over family size and increased productivity and opportunity for upskilling through education. 
CONCLUSION
Contraceptive implants have the dual potential to lower maternal morbidity and mortality by limiting exposure to pregnancy while addressing the high unmet need for family planning in rural PNG.
In this study, women using implants at 12 months indicated high satisfaction, low discontinuation and high efficacy rates. Given these findings, access to contraceptive implants through outreach services should be expanded in rural and low resource settings. 
